BDBM552956 N-[5-[2-(cyclohexylamino) pyrimidin-5-yl]-4-fluoro-2- (4-methylpiperazin-1- yl)phenyl]-6-oxo-4- (trifluoromethyl)-1H- pyridine-3-carboxamide::US11319299, Example 11

SMILES CN1CCN(c2cc(F)c(-c3cnc(NC4CCCCC4)nc3)cc2NC(=O)c2c[nH]c(=O)cc2C(F)(F)F)CC1

InChI Key InChIKey=RRQBQDOLKJVCNU-UHFFFAOYSA-N

Data  1 IC50  1 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 552956   

TargetWD repeat-containing protein 5(Human)
Propellon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 552956BDBM552956(N-[5-[2-(cyclohexylamino) pyrimidin-5-yl]-4-fluoro...)
Affinity DataKd:  5nMAssay Description:Exemplary compounds of the application were dissolved in 100% DMSO at 10 mM, assayed fresh, and then stored at −20° C. for repeat studies and o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
US Patent

TargetMLL1-WRAD2 complex(Human)
Propellon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 552956BDBM552956(N-[5-[2-(cyclohexylamino) pyrimidin-5-yl]-4-fluoro...)
Affinity DataIC50: 993nMAssay Description:Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
US Patent